Dry Age Related Macular Degeneration

Overview of mild, moderate and severe dry AMD including drusen and geographic atrophy.

What are Drusen?

The hallmark of dry AMD is macular drusen (see photo). Drusen are made up of lipids, a type of fatty protein. They may be the result of a failure of the eye to dispose of waste products that are produced when the photoreceptors of the eye drop off older parts of the cell. There are several types of drusen with different levels of risk. Drusen can be small, hard and scattered far apart from each other. They are round and distinct. This type may not create vision problems for a long time and may not even be an indication of macular degeneration. Some drusen can become larger, softer and closer together. Their edges are less distinct. When they get to that stage, there is a greater risk for developing wet macular degeneration and more severe vision loss. They can also disrupt the layers of the retina and may lead to retinal pigment epithelium detachment (PED). Your doctor can see these drusen during a dilated eye exam, even if you are not aware of a vision change. That is one reason why regular eye exams are so important. If you have the larger, soft drusen, your doctor will probably want you to come into the office for check-ups more often. If they do lead to wet macular degeneration, early treatment is essential.

What is Geographic Atrophy?

Geographic atrophy occurs when the photoreceptors (seeing part of the retina) no longer works and the patient develops a blind spot or spot of poor vision in the macula (see photo). Geographic atrophy (GA) is considered the late stage of the dry form of Age-related Macular Degeneration (AMD). It only occurs in about 10 percent of dry AMD patients. GA is usually a sharply delineated round or oval area of hypopigmentation, or apparent absence of the retinal pigment epithelium (RPE), in which choroidal vessels are more visible than in surrounding areas The most common sequence of events leading to GA is the progression of a large drusen to hyperpigmentation, followed by regression of the drusen, hypopigmentation and ultimately RPE cell death, with development of an atrophic area of retina and underlying choriocapillaris, sometimes preceded by the appearance of refractile deposits. This usually takes more than 5 years. Less frequently, GA can follow a drusenoid RPE detachment, regression of a CNV membrane or a RPE rupture. As other forms of late AMD, GA tends to be bilateral (over 50% of cases) and there is high symmetry between eyes for total atrophic area, presence of peripapillary atrophy and enlargement rate. GA often first develops surrounding the fovea, sparing the central area.

What is Progressive Geographic Atrophy?

Geographic atrophy can progress and lead to vision loss. When people with dry AMD lose vision, it is almost always from geographic atrophy. The animated image with this text shows growing geographic atrophy over 3 years in an 86 year old patient. This person is fortunate to have good vision because the dark areas of geographic atrophy are not yet affecting the central vision. Given the progression, the central vision will likely be affected within about 10 years. The images are fundus autofluorescent images that are useful for following geographic atrophy because the atrophy shows up as well delineated dark spots.

What is Pattern Dystrophy?

Pattern dystrophy is a type of dry age-related macular degeneration that involves mostly the very center of the macula. There are several types of pattern dystrophy. The image with this text is of a patient with adult vitelliform macular dystrophy. The image shows the buildup of abnormal deposits under the retina in the center of the macula. Unlike typical dry macular degeneration where the buildup of material is below the retinal pigment epithelium, in pattern dystrophy, the buildup of material is above the pigment epithelium and directly beneath the retina (see asterisks on image). Pattern dysrophy is autosomal dominant, usually presents at a younger age than typical dry AMD, and usually does not progress to wet AMD.

Pattern Dystrophy

What about Diet?

Patients who consume fruits and vegetables have the lowest rates of macular degeneration development. Lutein, a carotenoid pigment found exclusively in fruit and vegetables, serves as the primary protector of the eye. Lutein accumulates in the macula and likely blocks the damage caused by sunlight, one proposed cause of AMD. Fruits and vegetables are also high in antioxidant vitamins such as Beta- carotene, Vitamin E, and Vitamin C. Green leafy vegetables and other colorful foods like kiwi, squash, red grapes, and corn are good sources of Lutein. Other dietary habits have been shown to increase the risk of AMD. Individuals with a higher percentage of vegetable, monounsaturated, and polyunsaturated fats in their diet have higher rates of Wet AMD development. Diets rich in Omega 3 fatty acids reduce the risk of vision loss. These are found naturally in cold-water fish such as salmon and tuna, and in flaxseeds and flaxseed oil. Two servings of fish per week are adequate.

What about Vitamins?

The Age-Related Eye Disease Study 2 showed that among people at high risk for developing late-stage, or wet, macular degeneration (such as those who have large amounts of drusen or who have significant vision loss in at least one eye), taking a dietary supplement of vitamin C, vitamin E, lutein and zeaxanthin, along with zinc, lowered the risk of macular degeneration progressing to advanced stages by at least 25 percent. The supplements did not appear to provide a benefit for people with minimal macular degeneration or people without evidence of the disease during the course of the study. These vitamins contain a mixture of Vitamins C and E, Lutein, Zeaxanthin, Zing and Copper. Another large study in women showed a benefit from taking folic acid and vitamins B6 and B12. It is very important to remember that vitamin supplements are not a cure for macular degeneration, nor will they give you back vision that you may have already lost from the disease. However, these supplements do play a key role in helping some people at high risk for developing advanced (wet) AMD to maintain their vision, or slow down the progression of the disease.

What about Amsler Grid?

One of the first signs of macular degeneration can be wavy, broken or distorted lines OR a blurred or missing area of vision. The Amsler Grid can help you spot these early. Early detection of wet AMD is critical because laser treatment, when indicated, is most successful when performed before damage occurs. Since dry AMD can lead to development of wet AMD, most patients should use the Amsler Grid. Check with your eye doctor to find out how often you should use this test. Wear your reading glasses, if you normally use them and sit about 14 inches away from the screen. Check one eye at a time. Cover the eye you are not testing. Focus on the dark dot in the center of the grid. While looking at this dot, you still should be aware of the lines of the grid. Notice if any of the lines are distorted or broken or if there are blurred areas.

Download Amsler Grid

Dry Macular Degeneration NEWS

Below are current articles from a Google News Feed on Dry Macular Degeneration

Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness  Medical Xpress

Fight for Sight funded research published this week in Clinical Epigenetics, has identified new genes linked to the development of age-related macular ...

Researchers identify new genes linked to development of age-related macular degeneration  News-Medical.net

Fight for Sight funded research published this week in Clinical Epigenetics, has identified new genes linked to the development of age-related macular ...

Stem Cell Therapy Shows Early Promise Against Macular Degeneration  HealthDay

Age-related macular degeneration is the leading cause of vision loss in seniors, and existing treatments are few.

Researchers rescue photoreceptors, prevent blindness in animal models of age-related macular degeneration: Findings set stage for first clinical trial of stem cell-based therapeutic approach for AMD  Science Daily

Using a novel patient-specific stem cell-based therapy, researchers prevented blindness in animal models of geographic atrophy, the advanced 'dry' form of ...

Pixium Vision's Retinal Implant Lets Patients with Macular Degeneration See Patterns  Labiotech.eu

An electronic chip from French company Pixium Vision, inserted behind the retina to treat age-related macular degeneration, has shown excellent results in a ...

Research Roundup: Preventing macular degeneration blindness; A vaccine to the bio-terrorism toxin ricin and more!  Speaking of Research

Welcome to this week's Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week.

Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData  Clinical Leader

The age-related macular degeneration (AMD) market has been dominated by big pharma companies and their pipeline candidates are ensuring a share of...

BioTime, Orbit Biomedical to collaborate on OpRegen subretinal delivery for dry AMD  Healio

BioTime has entered into a research and option agreement with Orbit Biomedical regarding technology to deliver OpRegen to treat dry age-related macular ...

NIH researchers report animal model validation for stem cell-based approach to advanced dry AMD  Endpoints News

A group of NIH researchers say they have laid the groundwork needed to tackle the root cause of an advanced form of age-related macular degeneration by ...

Stem cell patch preserves vision in rodents and pigs with dry AMD  AOP

Researchers were able to prevent blindness in animal models of geographic atrophy.

Gemini to initiate CLARITY dry AMD disease registry and study  Healio

Gemini Therapeutics announced a disease registry and natural history study to identify and characterize disease progression in patients with non-central ...

A focus on Age-related Macular Degeneration this World Braille Day  Lexology

World Braille Day is observed every year on 4 January to celebrate the invention of braille. Braille is a tactile reading and writing system…

Eyeing Improvement: Fine-Tuning Anti-VEGF for Macular Degeneration  MD Magazine

Anti-VEGF injection therapy is the proven choice of care for AMD and DME. Still, concerns about dosing, costs, and convenience persist into 2019.

Pixium Vision announces its PRIMA chip successfully met interim study endpoints for dry AMD  PharmaLive

Written by: GlobeNewswire | support@globenewswire.com | Dated: Tuesday, January 8th, 2019. Pixium Vision announces its wireless PRIMA chip successfully ...

5 Medical Innovations That May Help Cure Blindness  Interesting Engineering

As people get older, it is almost inevitable that they will lose their eyesight to some degree. These 5 medical innovations hope to change that.

Regenxbio Inc (NASDAQ:RGNX) Sees a Continued Progress Across Programs; With Promising Results on RGX-314 for The Wet Age-Related Macular Degeneration  FDA Headlines

Jan 18, 2019 | Business. Regenxbio Inc (NASDAQ:RGNX) Sees a Continued Progress Across Programs; With Promising. Not all companies are lucky when ...

OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy  Markets Insider

SUWON, South Korea, Jan. 18, 2019 /PRNewswire/ -- OLX10020, a cell-penetrating asymmetric siRNA ('cp-asiRNA') against a novel target (Undisclosed) for ...

Stem cell remedy reveals early promise towards macular degeneration  Infosurhoy

Age-related macular degeneration is the leading cause of vision loss in seniors, and existing treatments are few. But now, experiments in pigs and rats suggest ...

Global Juvenile Macular Degeneration Treatment Market 2019- Acucela Inc., Alkeus Pharmaceuticals Inc, Astellas Pharma Inc  reportsherald.com

The Global Juvenile Macular Degeneration Treatment Market report enfolds crucial statistical data of sales and revenue based on leading segment such as type, ...

Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies  Nasdaq

Aerie Pharmaceuticals, Inc. AERI announced that the FDA has reviewed the Investigational New Drug (IND) application for AR-1105 (dexamethasone ...

MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark Office Covering the Use of MANF or CDNF as a Treatment for Glaucoma, Macular Degeneration and Retinitis Pigmentosa  Nasdaq

New York, NY, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience ...

Age-Related Macular Degeneration: 5 Things to Know  Medscape

A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for.

Ask a Doctor: What to do about dry macular degeneration  Chattanooga Times Free Press

I have been diagnosed with dry macular degeneration. What can I do now?

Blindness: Macular Degeneration Implant Treatment  Healthline

Researchers say the implant process could eventually be a treatment for the loss of eyesight experienced by millions as they grow older.

Stem Cells to Treat Visual Impairments in Elderly  Asharq Al-awsat English

A team of US scientists will kick off later this year clinical trials to treat visual impairments in the elderly, caused by macular degeneration, a common disorder that ...

Researchers are one step closer to developing eye drops to treat age-related macular degeneration  Medical Xpress

Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration ...

Stem Cells Show Promise For Macular Degeneration  WebMD

A new stem cell transplant might help preserve or even restore vision being lost to the dry form of age-related macular degeneration.

OpRegen shows positive phase 1/2a study results for dry AMD  Healio

CHICAGO — OpRegen, a retinal pigment epithelium cell therapy transplant for dry age-related macular degeneration, has shown signs of improving the retina ...

Hope for new treatments buoys macular degeneration patients  The Boston Globe

Scientists are experimenting with dozens of new treatments, including about 20 in clinical trials, to combat an eye disease that afflicts more than 9 million ...

Ask the Expert: Macular degeneration can lead to difficulty reading, recognizing faces and performing other fine tasks  Baltimore Sun

Macular degeneration is a disease of the eye that doesn't lead to total blindness, but in its advanced stages can cause blind areas. This can make it hard for ...

Implant Poised to Transform Macular Degeneration Treatment  Medscape

A system that delivers ranibizumab without injections could be a turning point for patients with neovascular age-related macular degeneration, results from the ...

Head to Head Survey: La Jolla Pharmaceutical (LJPC) vs. Outlook Therapeutics (OTLK)  Fairfield Current

La Jolla Pharmaceutical (NASDAQ:LJPC) and Outlook Therapeutics (NASDAQ:OTLK) are both small-cap medical companies, but which is the superior business ...

Age-Related Macular Degeneration Drug Combo Scrapped Despite Safe Profile  Specialty Pharmacy Times

Ophthotech Corp. said it won't move forward with further clinical trials of its complement factor C5 inhibitor for the treatment of wet age-related macular ...

Patient Voices: Macular Degeneration  New York Times

Five men and women speak about their lives with progressive vision loss.

The blood test that could save sight  Medical Xpress

A new blood test is being developed at The Australian National University (ANU) that can detect patients at risk of dry age-related macular degeneration (AMD) ...

How to spot age-related macular degeneration  The Guardian

Every day in the UK, nearly 200 people develop a condition that can lead to visual impairment or even blindness. How do you identify the symptoms and what's ...

Stem cell implant improves dry macular degeneration  BioNews

A stem cell implant appears to be safe, suggest the results of a clinical trial for the dry form of age-related macular degeneration (AMD). In dry AMD, a layer of ...

Don't let macular degeneration get in the way of your life  The Grand Junction Daily Sentinel

It's a dewy morning in the forest as you and your partner make your way through the weekend hike. You're enjoying the sounds of nature but having trouble ...

Revolutionary eye drops to treat age-related macular degeneration  Drug Target Review

Revolutionary eye drops to treat age-related macular degeneration - developing an eye drop that could revolutionise treatment for AMD.

Metformin for Macular Degeneration  Healthline

The popular diabetes medication, metformin, may soon be used not just to regulate blood sugar but to protect against a common form of blindness, called ...

Change Within the Eye May Be Early Warning for Macular Degeneration  HealthDay

FRIDAY, Nov. 9, 2018 (HealthDay News) -- Age-related eye disease is a worldwide problem that costs people not only their vision, but also hundreds of billions ...

Easier treatment for age-related macular degeneration shows promise in clinical study  News-Medical.net

A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months ...

Drug Pipeline for Macular Degeneration in Focus at AAO  Medscape

Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the ...

29th Int’l Conference of the Islamic Affairs Supreme Council Kicks off in Cairo  Asharq Al-awsat English

The 29th International Conference of the Supreme Council for Islamic Affairs got underway in Cairo on Saturday, reported the Saudi Press Agency. The event is ...

AMD Monitoring Comes Home: The Promise of Remote Tech  Medscape

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older Americans. AMD is a degenerative disease that affects the macula, ...

Has UVa Found a Cure for Macular Degeneration?  WMRA Public Radio

Macular degeneration may not get as much attention as Alzheimer's disease or breast cancer, but nearly one-third of people over 80 are affected by it. One.

Fewer Injections With New Wet Macular Degeneration Therapies  Medscape

New treatments in development — including gene therapy — will likely mean fewer injections for patients with neovascular age-related macular degeneration, ...

EyeMax Mono IOL shows promise in patients with macular disease  Healio

Visual acuity improved in patients with geographic atrophy who underwent cataract surgery and implantation of a novel monofocal IOL in the capsular bag, ...

Retinal implant designed to replace support cells damaged by dry age-related macular degeneration  Science Daily

Researchers have published preliminary results of a first-in-human clinical trial for dry age-related macular degeneration (AMD). Four patients received implants ...

5 questions: Breakthroughs in treatment for a common cause of vision loss among US seniors  Philly.com

The standard treatment has been regular injections to the eyeball. So, not surprisingly, an active area of research has focused on finding alternatives, including ...

Dry AMD: Oxurion licences heparanase blockers from Beta Therapeutics  European Biotechnology

Oxurion NV and Beta Therapeutics Inc have inked an R&D agreement aimed to develop new heparanase inhibitors to treat dry AMD.

Wills Eye Hospital releases new implant to help macular degeneration  KYW Newsradio 1060

PHILADELPHIA (KYW Newsradio) — There may soon be a way to preserve your vision with a lot less hassle.

Head-To-Head Survey: Outlook Therapeutics (OTLK) & Allena Pharmaceuticals (ALNA)  Fairfield Current

Allena Pharmaceuticals (NASDAQ:ALNA) and Outlook Therapeutics (NASDAQ:OTLK) are both small-cap medical companies, but which is the better stock?

Tiny eye device could make big difference for millions with blinding disease  Philly.com

Wills Eye Hospital has helped test an implantable delivery system for a widely used medication for age-related macular degeneration.

Macular Degeneration: Stem Cells Restore Sight in Small Study  Medscape

Doctors in the UK say they have taken an important step towards treating a common form of blindness – wet age-related macular degeneration (AMD).

Dry Age-Related Macular Degeneration | A Drug Pipeline Analysis Report 2018 | Technavio  Business Wire

Technavio has published a new report on the drug development pipeline for dry age-related macular degeneration, including a study of the molecules.

62year old Lagos woman gives away Eye treatment Remedy that Reverses Glaucoma, Cataracts and Improves Vision without eye drops  Vanguard

Glaucoma. Cataracts. Blurry vision. Age-related Macular Degeneration (AMD). Myopia. If not detected and treated early, these are vision problems in the elderly ...

Stem cells treat macular degeneration  Medical Xpress

In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.

Unafraid to Ask More: Macular Degeneration  University of Virginia

A team of UVA researchers set out to cure macular degeneration. What they discovered may protect people from this disease – as well as many other ...

Macular degeneration: 'I've been given my sight back'  BBC News

Doctors have taken a major step towards curing the most common form of blindness in the UK - age-related macular degeneration. Douglas Waters, 86, could ...

The burden of neovascular age-related macular degeneration: a patient' | OPTH  Dove Medical Press

The burden of neovascular age-related macular degeneration: a patient's perspective Kimberly L Spooner,1,2 Cleopatra T Mhlanga,1 Thomas H Hong,1 ...

LumiThera LT-300 Device For Treating Dry Advanced Macular Degeneration Granted CE Mark  PR Newswire

SEATTLE, June 22, 2018 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company focused on developing non-invasive ...

Eye Implant to Halt, Reverse Dry Age-Related Macular Degeneration |  Medgadget

Dry age-related macular degeneration is an all too common, untreatable disease that eventually results in blindness. It is caused by the retinal pigment.

Implanting stem cell 'patch' can restore vision  Futurity: Research News

Clinical trial results show that a stem cell patch can treat sudden, severe sight loss due to a form of macular degeneration.

Neovascular age-related macular degeneration: intraocular inflammatory | OPTH  Dove Medical Press

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment Pear Pongsachareonnont,1 ...

Mediterranean diet prevents a leading cause of blindness, study suggests: Research shows we can all eat our way to better eye health  Science Daily

Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration (AMD), a leading cause of blindness in ...

Drug Slows Atrophy in Dry AMD | Medpage Today  MedPage Today

No vision improvement with complement C3 inhibitor.

Calcifications in the eye increase risk for progression to advanced AMD by more than six times  Medical Xpress

Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration (AMD). Experts from Queen's University ...

Bionic retina looks good in early safety study  Optics.org

First patients to receive radical treatment for dry form of age-related macular degeneration (AMD) able to see patterns including letters and numbers.

New Stem Cell Treatment Reverses Vision Loss in 2 Patients  Live Science

Two people who were going blind can now see the word in much greater detail than before thanks to an experimental stem cell treatment for macular ...

Modeling the most common form of vision loss in older adults  Penn: Office of University Communications

Age-related macular degeneration is the leading cause of vision loss in people older than 50. Kathleen Boesze-Battaglia and colleagues have developed a ...

Macular Degeneration: Managing This Vision Condition  U.S. News & World Report

Helyn Guerry, 88, of Houston, looks around her room but struggles to make out the objects directly in front of her. Macular degeneration, a common eye condition ...

Change Within Eye A Hint of Macular Degeneration?  WebMD

The investigators discovered that calcifications in the retina -- the thin layer of tissue that lines the back of the eye -- raise the risk of advanced age-related ...

UVA Doctor States Possible Solution to Stop Macular Degeneration  NBC 29 News

A University of Virginia doctor thinks he could have a cure for a common type of blindness. Dr. Jayakrishna Ambati, who's the director of the Center for Advanced ...

VIDEO: Topical treatment of AMD shows promise in early stages of clinical trial  Healio

VIENNA — At the Euretina meeting, Hemal Mehta, MD, speaks about the early results of the PanOptica clinical trial on a new molecule for the topical treatment of ...

Loma Linda Patient First in California to Receive a Telescope Implant for Macular Degeneration after Having Cataract Surgery  GlobeNewswire

LOMA LINDA, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- A patient at Loma Linda University Eye Institute became the first in California to receive the Miniature ...

An orange a day keeps macular degeneration away: 15-year study  Science Daily

A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Head to Head Analysis: Stellus Capital Investment (SCM) & Elron Electronic Industries (ELRNF)  Fairfield Current

Stellus Capital Investment (NYSE:SCM) and Elron Electronic Industries (OTCMKTS:ELRNF) are both small-cap finance companies, but which is the superior ...

Reproducibility of Macular Thickness Measurements in Eyes Affected by Dry Age-Related Macular Degeneration From Two Different SD-OCT Instruments  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:To compare macular thickness measurement algorithms of two different ...

Patients with Concurrent Cataracts, Wet AMD Safe to Undergo Cataract Surgery  MD Magazine

Most patients, whether or not they had preoperative fluid, saw improved BCVA post-surgery, and there were no significant differences in central subfield ...

Optos Announces Collaboration for Monitoring and Treating Dry Age-Related Macular Degeneration in Europe  Business Wire

DUNFERMLINE, Scotland--(BUSINESS WIRE)--Optos Plc, a subsidiary of Nikon Corporation, Japan and the only ultra-widefield retinal imaging company for eye ...

Diabetes medication may protect against a common cause of blindness: Metformin may reduce the risk of age-related macular degeneration  Science Daily

Researchers have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related ...

Novel Imaging Technique Provides Potential Improvement for AMD  MD Magazine

A new imaging technique may provide improvements to the diagnosis and treatment of diseases like age-related macular degeneration (AMD).

OCT Angiography Predicts Exudation in Macular Degeneration  Medscape

Optical coherence tomography (OCT) angiography can predict progression of age-related macular degeneration and identify which patients might benefit from ...

Xbrane Biopharma announces acceptance of initiation of Xlucane clinical trial in the US  Nasdaq

The Food and Drug Administration and the Central Ethics Committee in the United States have accepted Xbranes IND application for initiation of the.

A Report On Growing Age Related Macular Degeneration (AMD) Market By Wet and Dry Eye, Age, Treatment and Top Players - Global Forecast 2018-2023 |  Medgadget

Global Age Related Macular Degeneration Market report examines the market position and viewpoint of the market globally, from various angles, such as key.

Stem Cell-Based Retinal Implant May Halt Progression of Dry AMD  MD Magazine

A stem cell-based implant has been shown in a phase 1/2a trial to not only halt AMD disease progression but possibly improve vision.

Charity fears elderly on Scots island will go blind over 'cruel' policy to ferry patients for sight treatment  HeraldScotland

A NATIONAL charity has condemned a 'cruel' policy that forces elderly patients in Shetland to endure 36-hour round ferry trips for treatment to…

Eye implant made from stem cells could halt macular degeneration  FierceBiotech

A team of scientists led by the University of Southern California's Roski Eye Institute built a retinal implant from embryonic stem cells, and they have early but ...

February is Age-related Macular Degeneration Month  Healio

Age-related macular degeneration, characterized by the loss of central vision, affects 1.65 million individuals in the United States and is the leading cause of ...

Stem cell-based retinal implant shows promising results for advanced dry AMD  Healio

A first-of-its-kind stem cell-based retinal implant for patients with advanced dry age-related macular degeneration was well-tolerated and showed promising ...

Reducing Treatment Burden in Neovascular Age-related Macular Degeneration: What's Now? What's Next?  Healio

Education Lab | Neovascular, or “wet” age-related macular degeneration (nAMD) imposes a high burden on patients and eye care providers alike, as optimal ...

LumiThera LT-300 granted CE mark for treating dry AMD  Healio

The European Union has granted a CE mark for the LT-300 light delivery system, a treatment device for dry age-related macular degeneration, LumiThera ...

Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies  Xconomy

Many patients with the more severe form of age-related macular degeneration, a type of vision loss, have trouble with the standard treatment---a.

Why everyone over 50 needs a retina eye exam  Queens Chronicle

Macular degeneration is the leading cause of vision loss affecting more than 10 million Americans. In addition, diabetic retinopathy has afflicted over 8 million ...

Zimura/Lucentis Combo Safe, But Company Decides Not to Move Forward  MD Magazine

Ophthotech says it's sidelining its Zimura/Lucentis program despite positive phase 2a results.

RegenXBio Gene Therapy Shows Early Promise For Eye Disease; Cholesterol Treatment Results Mixed  Forbes

A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness.

New gene therapy corrects a form of inherited macular degeneration in canine model  Science Daily

Researchers have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating ...

Is Blue Light From Your Smart Phone Harmful To Your Eyes?  Forbes

While the habit of checking your smartphone at night may seem like an innocent practice, the reality is that it could actually be leading to permanent damage to ...

Ionis may have found a home for dry AMD drug with Roche in $760M deal  FierceBiotech

Ionis signed on with Roche to help develop its RNA-based drug for advanced dry AMD and other diseases, in a deal worth up to $760 million, after being ...

» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America